Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
September-2023 Volume 28 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
September-2023 Volume 28 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Review Open Access

The NLRP3 inflammasome in viral infection (Review)

  • Authors:
    • Qiaoli Zheng
    • Chunting Hua
    • Qichang Liang
    • Hao Cheng
  • View Affiliations / Copyright

    Affiliations: Department of Dermatology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310016, P.R. China
    Copyright: © Zheng et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 160
    |
    Published online on: July 6, 2023
       https://doi.org/10.3892/mmr.2023.13047
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The interplay between pathogen and host determines the immune response during viral infection. The Nod‑like receptor (NLR) protein 3 inflammasome is a multiprotein complex that induces the activation of inflammatory caspases and the release of IL‑1β, which play an important role in the innate immune responses. In the present review, the mechanisms of the NLR family pyrin domain containing 3 inflammasome activation and its dysregulation in viral infection were addressed.
View Figures

Figure 1

Figure 2

View References

1 

Schroder K and Tschopp J: The inflammasomes. Cell. 140:821–832. 2010. View Article : Google Scholar : PubMed/NCBI

2 

Fusco R, Siracusa R, Genovese T, Cuzzocrea S and Di Paola R: Focus on the role of NLRP3 inflammasome in diseases. Int J Mol Sci. 21:42232020. View Article : Google Scholar : PubMed/NCBI

3 

Farag NS, Breitinger U, Breitinger HG and El Azizi MA: Viroporins and inflammasomes: A key to understand virus-induced inflammation. Int J Biochem Cell Biol. 122:1057382020. View Article : Google Scholar : PubMed/NCBI

4 

Kelley N, Jeltema D, Duan Y and He Y: The NLRP3 inflammasome: An overview of mechanisms of activation and regulation. Int J Mol Sci. 20:33282019. View Article : Google Scholar : PubMed/NCBI

5 

Barnett KC, Li S, Liang K and Ting JPY: A 360° view of the inflammasome: Mechanisms of activation, cell death, and diseases. Cell. 186:2288–2312. 2023. View Article : Google Scholar : PubMed/NCBI

6 

Chou WC, Jha S, Linhoff MW and Ting JPY: The NLR gene family: from discovery to present day. Nat Rev Immunol. Mar 27–2023.(Epub ahead of print). View Article : Google Scholar

7 

Chai R, Li Y, Shui L, Ni L and Zhang A: The role of pyroptosis in inflammatory diseases. Front Cell Dev Biol. 11:11732352023. View Article : Google Scholar : PubMed/NCBI

8 

Zhan X, Li Q, Xu G, Xiao X and Bai Z: The mechanism of NLRP3 inflammasome activation and its pharmacological inhibitors. Front Immunol. 13:11099382023. View Article : Google Scholar : PubMed/NCBI

9 

Agostini L, Martinon F, Burns K, McDermott MF, Hawkins PN and Tschopp J: NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. Immunity. 20:319–325. 2004. View Article : Google Scholar : PubMed/NCBI

10 

Song JY, Park YM and Choi SY: Type 2 human papillomavirus E7 attenuates E-cadherin expression in human keratinocytes. J Microbiol. 59:616–625. 2021. View Article : Google Scholar : PubMed/NCBI

11 

Yu TG, Cha JS, Kim G, Sohn YK, Yoo Y, Kim U, Song JJ, Cho HS and Kim HS: Oligomeric states of ASC specks regulate inflammatory responses by inflammasome in the extracellular space. Cell Death Discov. 9:1422023. View Article : Google Scholar : PubMed/NCBI

12 

Proell M, Gerlic M, Mace PD, Reed JC and Riedl SJ: The CARD plays a critical role in ASC foci formation and inflammasome signalling. Biochem J. 449:613–621. 2013. View Article : Google Scholar : PubMed/NCBI

13 

Guo Y, Gu D, Huang T, Li A, Zhou Y, Kang X, Meng C, Xiong D, Song L, Jiao X and Pan Z: Salmonella Enteritidis T1SS protein SiiD inhibits NLRP3 inflammasome activation via repressing the mtROS-ASC dependent pathway. PLoS Pathog. 19:e10113812023. View Article : Google Scholar : PubMed/NCBI

14 

de Souza JG, Starobinas N and Ibañez OCM: Unknown/enigmatic functions of extracellular ASC. Immunology. 163:377–388. 2021. View Article : Google Scholar : PubMed/NCBI

15 

Ross C, Chan AH, von Pein JB, Maddugoda MP, Boucher D and Schroder K: Inflammatory caspases: Toward a unified model for caspase activation by inflammasomes. Annu Rev Immunol. 40:249–269. 2022. View Article : Google Scholar : PubMed/NCBI

16 

Triantafilou K: Enigmatic inflammasomes. Immunology. 162:249–251. 2021. View Article : Google Scholar : PubMed/NCBI

17 

Wang C, Yang T, Xiao J, Xu C, Alippe Y, Sun K, Kanneganti TD, Monahan JB, Abu-Amer Y, Lieberman J and Mbalaviele G: NLRP3 inflammasome activation triggers gasdermin D-independent inflammation. Sci Immunol. 6:eabj38592021. View Article : Google Scholar : PubMed/NCBI

18 

Zhen Y and Zhang H: NLRP3 inflammasome and inflammatory bowel disease. Front Immunol. 10:2762019. View Article : Google Scholar : PubMed/NCBI

19 

Voet S, Srinivasan S, Lamkanfi M and van Loo G: Inflammasomes in neuroinflammatory and neurodegenerative diseases. EMBO Mol Med. 11:e102482019. View Article : Google Scholar : PubMed/NCBI

20 

Tapia VS, Daniels MJD, Palazón-Riquelme P, Dewhurst M, Luheshi NM, Rivers-Auty J, Green J, Redondo-Castro E, Kaldis P, Lopez-Castejon G and Brough D: The three cytokines IL-1β, IL-18, and IL-1α share related but distinct secretory routes. J Biol Chem. 294:8325–8335. 2019. View Article : Google Scholar : PubMed/NCBI

21 

Long J, Sun Y, Liu S, Yang S, Chen C, Zhang Z, Chu S, Yang Y, Pei G, Lin M, et al: Targeting pyroptosis as a preventive and therapeutic approach for stroke. Cell Death Discov. 9:1552023. View Article : Google Scholar : PubMed/NCBI

22 

Devant P and Kagan JC: Molecular mechanisms of gasdermin D pore-forming activity. Nat Immunol. Jun 5–2023.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI

23 

Li Y, Song W, Tong Y, Zhang X, Zhao J, Gao X, Yong J and Wang H: Isoliquiritin ameliorates depression by suppressing NLRP3-mediated pyroptosis via miRNA-27a/SYK/NF-κB axis. J Neuroinflammation. 18:12021. View Article : Google Scholar : PubMed/NCBI

24 

Mariathasan S, Weiss DS, Newton K, McBride J, O'Rourke K, Roose-Girma M, Lee WP, Weinrauch Y, Monack DM and Dixit VM: Cryopyrin activates the inflammasome in response to toxins and ATP. Nature. 440:228–232. 2006. View Article : Google Scholar : PubMed/NCBI

25 

Guo Y, Li L, Xu T, Guo X, Wang C, Li Y, Yang Y, Yang D, Sun B, Zhao X, et al: HUWE1 mediates inflammasome activation and promotes host defense against bacterial infection. J Clin Invest. 130:6301–6316. 2020. View Article : Google Scholar : PubMed/NCBI

26 

Zhang S, Zhang Y, Gan L, Wei F, Chai B, A Aljaafreh AAH, Liu X, Duan X, Jiang J, Wang X, et al: Progesterone suppresses Neisseria gonorrhoeae-induced inflammation through inhibition of NLRP3 inflammasome pathway in THP-1 cells and murine models. Front Microbiol. 12:5700932021. View Article : Google Scholar : PubMed/NCBI

27 

Muruve DA, Pétrilli V, Zaiss AK, White LR, Clark SA, Ross PJ, Parks RJ and Tschopp J: The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response. Nature. 452:103–107. 2008. View Article : Google Scholar : PubMed/NCBI

28 

Allen IC, Scull MA, Moore CB, Holl EK, McElvania-TeKippe E, Taxman DJ, Guthrie EH, Pickles RJ and Ting JP: The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA. Immunity. 30:556–565. 2009. View Article : Google Scholar : PubMed/NCBI

29 

Poeck H, Bscheider M, Gross O, Finger K, Roth S, Rebsamen M, Hannesschläger N, Schlee M, Rothenfusser S, Barchet W, et al: Recognition of RNA virus by RIG-I results in activation of CARD9 and inflammasome signaling for interleukin 1 beta production. Nat Immunol. 11:63–69. 2010. View Article : Google Scholar : PubMed/NCBI

30 

Zhou R, Tardivel A, Thorens B, Choi I and Tschopp J: Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat Immunol. 11:136–140. 2010. View Article : Google Scholar : PubMed/NCBI

31 

Walev I, Reske K, Palmer M, Valeva A and Bhakdi S: Potassium-inhibited processing of IL-1 beta in human monocytes. EMBO J. 14:1607–1614. 1995. View Article : Google Scholar : PubMed/NCBI

32 

Gurcel L, Abrami L, Girardin S, Tschopp J and van der Goot FG: Caspase-1 activation of lipid metabolic pathways in response to bacterial pore-forming toxins promotes cell survival. Cell. 126:1135–1145. 2006. View Article : Google Scholar : PubMed/NCBI

33 

Liu R, Liu Y, Liu C, Gao A, Wang L, Tang H, Wu Q, Wang X, Tian D, Qi Z and Shen Y: NEK7-mediated activation of NLRP3 inflammasome is coordinated by potassium Efflux/Syk/JNK signaling during Staphylococcus aureus infection. Front Immunol. 12:7473702021. View Article : Google Scholar : PubMed/NCBI

34 

Pelegrin P: P2X7 receptor and the NLRP3 inflammasome: Partners in crime. Biochem Pharmacol. 187:1143852021. View Article : Google Scholar : PubMed/NCBI

35 

Halle A, Hornung V, Petzold GC, Stewart CR, Monks BG, Reinheckel T, Fitzgerald KA, Latz E, Moore KJ and Golenbock DT: The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nat Immunol. 9:857–865. 2008. View Article : Google Scholar : PubMed/NCBI

36 

Hornung V, Bauernfeind F, Halle A, Samstad EO, Kono H, Rock KL, Fitzgerald KA and Latz E: Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat Immunol. 9:847–856. 2008. View Article : Google Scholar : PubMed/NCBI

37 

Cruz CM, Rinna A, Forman HJ, Ventura ALM, Persechini PM and Ojcius DM: ATP activates a reactive oxygen species-dependent oxidative stress response and secretion of proinflammatory cytokines in macrophages. J Biol Chem. 282:2871–2879. 2007. View Article : Google Scholar : PubMed/NCBI

38 

Cassel SL, Eisenbarth SC, Iyer SS, Sadler JJ, Colegio OR, Tephly LA, Carter AB, Rothman PB, Flavell RA and Sutterwala FS: The Nalp3 inflammasome is essential for the development of silicosis. Proc Natl Acad Sci USA. 105:9035–9040. 2008. View Article : Google Scholar : PubMed/NCBI

39 

Dostert C, Pétrilli V, Van Bruggen R, Steele C, Mossman BT and Tschopp J: Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science. 320:674–677. 2008. View Article : Google Scholar : PubMed/NCBI

40 

Koumangoye R: The role of Cl− and K+ efflux in NLRP3 inflammasome and innate immune response activation. Am J Physiol Cell Physiol. 322:C645–C652. 2022. View Article : Google Scholar : PubMed/NCBI

41 

Shio MT, Eisenbarth SC, Savaria M, Vinet AF, Bellemare MJ, Harder KW, Sutterwala FS, Bohle DS, Descoteaux A, Flavell RA and Olivier M: Malarial hemozoin activates the NLRP3 inflammasome through Lyn and Syk kinases. PLoS Pathog. 5:e10005592009. View Article : Google Scholar : PubMed/NCBI

42 

Latz E, Xiao TS and Stutz A: Activation and regulation of the inflammasomes. Nat Rev Immunol. 13:397–411. 2013. View Article : Google Scholar : PubMed/NCBI

43 

Shimada K, Crother TR, Karlin J, Dagvadorj J, Chiba N, Chen S, Ramanujan VK, Wolf AJ, Vergnes L, Ojcius DM, et al: Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis. Immunity. 36:401–414. 2012. View Article : Google Scholar : PubMed/NCBI

44 

Cabral A, Cabral JE, Wang A, Zhang Y, Liang H, Nikbakht D, Corona L, Hoffman HM and McNulty R: Differential binding of NLRP3 to non-oxidized and Ox-mtDNA mediates NLRP3 inflammasome activation. Commun Biol. 6:5782023. View Article : Google Scholar : PubMed/NCBI

45 

Zamyatina A and Heine H: Lipopolysaccharide recognition in the crossroads of TLR4 and caspase-4/11 mediated inflammatory pathways. Front Immunol. 11:5851462020. View Article : Google Scholar : PubMed/NCBI

46 

Rathinam VAK, Zhao Y and Shao F: Innate immunity to intracellular LPS. Nat Immunol. 20:527–533. 2019. View Article : Google Scholar : PubMed/NCBI

47 

Downs KP, Nguyen H, Dorfleutner A and Stehlik C: An overview of the non-canonical inflammasome. Mol Aspects Med. 76:1009242020. View Article : Google Scholar : PubMed/NCBI

48 

Naseer N, Zhang J, Bauer R, Constant DA, Nice TJ, Brodsky IE, Rauch I and Shin S: Salmonella enterica serovar typhimurium induces NAIP/NLRC4- and NLRP3/ASC-independent, caspase-4-dependent inflammasome activation in human intestinal epithelial cells. Infect Immun. 90:e00663212022. View Article : Google Scholar : PubMed/NCBI

49 

Baker PJ, Boucher D, Bierschenk D, Tebartz C, Whitney PG, D'Silva DB, Tanzer MC, Monteleone M, Robertson AA, Cooper MA, et al: NLRP3 inflammasome activation downstream of cytoplasmic LPS recognition by both caspase-4 and caspase-5. Eur J Immunol. 45:2918–2926. 2015. View Article : Google Scholar : PubMed/NCBI

50 

Schmid-Burgk JL, Gaidt MM, Schmidt T, Ebert TS, Bartok E and Hornung V: Caspase-4 mediates non-canonical activation of the NLRP3 inflammasome in human myeloid cells. Eur J Immunol. 45:2911–2917. 2015. View Article : Google Scholar : PubMed/NCBI

51 

Franchi L, Eigenbrod T and Núñez G: Cutting edge: TNF-alpha mediates sensitization to ATP and silica via the NLRP3 inflammasome in the absence of microbial stimulation. J Immunol. 183:792–796. 2009. View Article : Google Scholar : PubMed/NCBI

52 

Bauernfeind FG, Horvath G, Stutz A, Alnemri ES, MacDonald K, Speert D, Fernandes-Alnemri T, Wu J, Monks BG, Fitzgerald KA, et al: Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J Immunol. 183:787–791. 2009. View Article : Google Scholar : PubMed/NCBI

53 

Chen X, Liu G, Yuan Y, Wu G, Wang S and Yuan L: NEK7 interacts with NLRP3 to modulate the pyroptosis in inflammatory bowel disease via NF-κB signaling. Cell Death Dis. 10:9062019. View Article : Google Scholar : PubMed/NCBI

54 

Liu G, Chen X, Wang Q and Yuan L: NEK7: A potential therapy target for NLRP3-related diseases. Biosci Trends. 14:74–82. 2020. View Article : Google Scholar : PubMed/NCBI

55 

Sharif H, Wang L, Wang WL, Magupalli VG, Andreeva L, Qiao Q, Hauenstein AV, Wu Z, Núñez G, Mao Y and Wu H: Structural mechanism for NEK7-licensed activation of NLRP3 inflammasome. Nature. 570:338–343. 2019. View Article : Google Scholar : PubMed/NCBI

56 

Juliana C, Fernandes-Alnemri T, Kang S, Farias A, Qin F and Alnemri ES: Non-transcriptional priming and deubiquitination regulate NLRP3 inflammasome activation. J Biol Chem. 287:36617–36622. 2012. View Article : Google Scholar : PubMed/NCBI

57 

Py BF, Kim MS, Vakifahmetoglu-Norberg H and Yuan J: Deubiquitination of NLRP3 by BRCC3 critically regulates inflammasome activity. Mol Cell. 49:331–338. 2013. View Article : Google Scholar : PubMed/NCBI

58 

Lu B, Nakamura T, Inouye K, Li J, Tang Y, Lundbäck P, Valdes-Ferrer SI, Olofsson PS, Kalb T, Roth J, et al: Novel role of PKR in inflammasome activation and HMGB1 release. Nature. 488:670–674. 2012. View Article : Google Scholar : PubMed/NCBI

59 

Li Y, Lin X, Wang W, Wang W, Cheng S, Huang Y, Zou Y, Ke J and Zhu L: The proinflammatory role of guanylate-binding protein 5 in inflammatory bowel diseases. Front Microbiol. 13:9269152022. View Article : Google Scholar : PubMed/NCBI

60 

Yang CS, Kim JJ, Kim TS, Lee PY, Kim SY, Lee HM, Shin DM, Nguyen LT, Lee MS, Jin HS, et al: Small heterodimer partner interacts with NLRP3 and negatively regulates activation of the NLRP3 inflammasome. Nat Commun. 6:61152015. View Article : Google Scholar : PubMed/NCBI

61 

Hara H, Tsuchiya K, Kawamura I, Fang R, Hernandez-Cuellar E, Shen Y, Mizuguchi J, Schweighoffer E, Tybulewicz V and Mitsuyama M: Phosphorylation of the adaptor ASC acts as a molecular switch that controls the formation of speck-like aggregates and inflammasome activity. Nat Immunol. 14:1247–1255. 2013. View Article : Google Scholar : PubMed/NCBI

62 

Okada M, Matsuzawa A, Yoshimura A and Ichijo H: The lysosome rupture-activated TAK1-JNK pathway regulates NLRP3 inflammasome activation. J Biol Chem. 289:32926–32936. 2014. View Article : Google Scholar : PubMed/NCBI

63 

Humke EW, Shriver SK, Starovasnik MA, Fairbrother WJ and Dixit VM: ICEBERG: A novel inhibitor of interleukin-1beta generation. Cell. 103:99–111. 2000. View Article : Google Scholar : PubMed/NCBI

64 

Druilhe A, Srinivasula SM, Razmara M, Ahmad M and Alnemri ES: Regulation of IL-1beta generation by Pseudo-ICE and ICEBERG, two dominant negative caspase recruitment domain proteins. Cell Death Differ. 8:649–657. 2001. View Article : Google Scholar : PubMed/NCBI

65 

Lamkanfi M, Denecker G, Kalai M, D'hondt K, Meeus A, Declercq W, Saelens X and Vandenabeele P: INCA, a novel human caspase recruitment domain protein that inhibits interleukin-1beta generation. J Biol Chem. 279:51729–51738. 2004. View Article : Google Scholar : PubMed/NCBI

66 

Saleh M, Mathison JC, Wolinski MK, Bensinger SJ, Fitzgerald P, Droin N, Ulevitch RJ, Green DR and Nicholson DW: Enhanced bacterial clearance and sepsis resistance in caspase-12-deficient mice. Nature. 440:1064–1068. 2006. View Article : Google Scholar : PubMed/NCBI

67 

Bedoya F, Sandler LL and Harton JA: Pyrin-only protein 2 modulates NF-kappaB and disrupts ASC:CLR interactions. J Immunol. 178:3837–3845. 2007. View Article : Google Scholar : PubMed/NCBI

68 

Dorfleutner A, Bryan NB, Talbott SJ, Funya KN, Rellick SL, Reed JC, Shi X, Rojanasakul Y, Flynn DC and Stehlik C: Cellular pyrin domain-only protein 2 is a candidate regulator of inflammasome activation. Infect Immun. 75:1484–1492. 2007. View Article : Google Scholar : PubMed/NCBI

69 

Khare S, Ratsimandresy RA, de Almeida L, Cuda CM, Rellick SL, Misharin AV, Wallin MC, Gangopadhyay A, Forte E, Gottwein E, et al: The PYRIN domain-only protein POP3 inhibits ALR inflammasomes and regulates responses to infection with DNA viruses. Nat Immunol. 15:343–353. 2014. View Article : Google Scholar : PubMed/NCBI

70 

de Almeida L, Khare S, Misharin AV, Patel R, Ratsimandresy RA, Wallin MC, Perlman H, Greaves DR, Hoffman HM, Dorfleutner A and Stehlik C: The PYRIN domain-only protein POP1 inhibits inflammasome assembly and ameliorates inflammatory disease. Immunity. 43:264–276. 2015. View Article : Google Scholar : PubMed/NCBI

71 

Martin BN, Wang C, Willette-Brown J, Herjan T, Gulen MF, Zhou H, Bulek K, Franchi L, Sato T, Alnemri ES, et al: IKKα negatively regulates ASC-dependent inflammasome activation. Nat Commun. 5:49772014. View Article : Google Scholar : PubMed/NCBI

72 

Ito M, Yanagi Y and Ichinohe T: Encephalomyocarditis virus viroporin 2B activates NLRP3 inflammasome. PLoS Pathog. 8:e10028572012. View Article : Google Scholar : PubMed/NCBI

73 

Ermler ME, Traylor Z, Patel K, Schattgen SA, Vanaja SK, Fitzgerald KA and Hise AG: Rift Valley fever virus infection induces activation of the NLRP3 inflammasome. Virology. 449:174–180. 2014. View Article : Google Scholar : PubMed/NCBI

74 

Pinar A, Dowling JK, Bitto NJ, Robertson AA, Latz E, Stewart CR, Drummond GR, Cooper MA, McAuley JL, Tate MD and Mansell A: PB1-F2 peptide derived from avian influenza A virus H7N9 induces inflammation via activation of the NLRP3 inflammasome. J Biol Chem. 292:826–836. 2017. View Article : Google Scholar : PubMed/NCBI

75 

Xu J, Zhou Z, Zheng Y, Yang S, Huang K and Li H: Roles of inflammasomes in viral myocarditis. Front Cell Infect Microbiol. 13:11499112023. View Article : Google Scholar : PubMed/NCBI

76 

Wang W, Li G, De Wu, Luo Z, Pan P, Tian M, Wang Y, Xiao F, Li A, Wu K, et al: Zika virus infection induces host inflammatory responses by facilitating NLRP3 inflammasome assembly and interleukin-1β secretion. Nat Commun. 9:1062018. View Article : Google Scholar : PubMed/NCBI

77 

de Castro-Jorge LA, de Carvalho RVH, Klein TM, Hiroki CH, Lopes AH, Guimarães RM, Fumagalli MJ, Floriano VG, Agostinho MR, Slhessarenko RD, et al: The NLRP3 inflammasome is involved with the pathogenesis of Mayaro virus. PLoS Pathog. 15:e10079342019. View Article : Google Scholar : PubMed/NCBI

78 

Shrivastava G, Visoso-Carvajal G, Garcia-Cordero J, Leon-Juarez M, Chavez-Munguia B, Lopez T, Nava P, Villegas-Sepulveda N and Cedillo-Barron L: Dengue virus serotype 2 and its non-structural proteins 2A and 2B activate NLRP3 inflammasome. Front Immunol. 11:3522020. View Article : Google Scholar : PubMed/NCBI

79 

Xie WH, Ding J, Xie XX, Yang XH, Wu XF, Chen ZX, Guo QL, Gao WY, Wang XZ and Li D: Hepatitis B virus X protein promotes liver cell pyroptosis under oxidative stress through NLRP3 inflammasome activation. Inflamm Res. 69:683–696. 2020. View Article : Google Scholar : PubMed/NCBI

80 

Zhi X, Zhang Y, Sun S, Zhang Z, Dong H, Luo X, Wei Y, Lu Z, Dou Y, Wu R, et al: NLRP3 inflammasome activation by Foot-and-mouth disease virus infection mainly induced by viral RNA and non-structural protein 2B. RNA Biol. 17:335–349. 2020. View Article : Google Scholar : PubMed/NCBI

81 

Zhao C and Zhao W: NLRP3 inflammasome-A key player in antiviral responses. Front Immunol. 11:2112020. View Article : Google Scholar : PubMed/NCBI

82 

Harris J and Borg NA: The multifaceted roles of NLRP3-modulating proteins in virus infection. Front Immunol. 13:9874532022. View Article : Google Scholar : PubMed/NCBI

83 

Chen IY, Moriyama M, Chang MF and Ichinohe T: Severe acute respiratory syndrome coronavirus viroporin 3a activates the NLRP3 inflammasome. Front Microbiol. 10:502019. View Article : Google Scholar : PubMed/NCBI

84 

Guo HC, Jin Y, Zhi XY, Yan D and Sun SQ: NLRP3 inflammasome activation by viroporins of animal viruses. Viruses. 7:3380–3391. 2015. View Article : Google Scholar : PubMed/NCBI

85 

Freeman TL and Swartz TH: Targeting the NLRP3 inflammasome in Severe COVID-19. Front Immunol. 11:15182020. View Article : Google Scholar : PubMed/NCBI

86 

da Costa LS, Outlioua A, Anginot A, Akarid K and Arnoult D: RNA viruses promote activation of the NLRP3 inflammasome through cytopathogenic effect-induced potassium efflux. Cell Death Dis. 10:3462019. View Article : Google Scholar : PubMed/NCBI

87 

Guo S, Yang C, Diao B, Huang X, Jin M, Chen L, Yan W, Ning Q, Zheng L, Wu Y and Chen Y: The NLRP3 inflammasome and IL-1β accelerate immunologically mediated pathology in experimental viral fulminant hepatitis. PLoS Pathog. 11:e10051552015. View Article : Google Scholar : PubMed/NCBI

88 

Guo H, Gao J, Taxman DJ, Ting JPY and Su L: HIV-1 infection induces interleukin-1β production via TLR8 protein-dependent and NLRP3 inflammasome mechanisms in human monocytes. J Biol Chem. 289:21716–21726. 2014. View Article : Google Scholar : PubMed/NCBI

89 

Shil NK, Pokharel SM, Banerjee AK, Hoffman M and Bose S: Inflammasome antagonism by human parainfluenza virus type 3 c protein. J Virol. 92:e01776–17. 2018. View Article : Google Scholar : PubMed/NCBI

90 

Moriyama M, Nagai M, Maruzuru Y, Koshiba T, Kawaguchi Y and Ichinohe T: Influenza virus-induced oxidized DNA activates inflammasomes. iScience. 23:1012702020. View Article : Google Scholar : PubMed/NCBI

91 

Barlan AU, Danthi P and Wiethoff CM: Lysosomal localization and mechanism of membrane penetration influence nonenveloped virus activation of the NLRP3 inflammasome. Virology. 412:306–314. 2011. View Article : Google Scholar : PubMed/NCBI

92 

Chakrabarti A, Banerjee S, Franchi L, Loo YM, Gale M Jr, Núñez G and Silverman RH: RNase L activates the NLRP3 inflammasome during viral infections. Cell Host Microbe. 17:466–477. 2015. View Article : Google Scholar : PubMed/NCBI

93 

Subramanian N, Natarajan K, Clatworthy MR, Wang Z and Germain RN: The adaptor MAVS promotes NLRP3 mitochondrial localization and inflammasome activation. Cell. 153:348–361. 2013. View Article : Google Scholar : PubMed/NCBI

94 

Li J, Hu L, Liu Y, Huang L, Mu Y, Cai X and Weng C: DDX19A senses viral RNA and mediates NLRP3-dependent inflammasome activation. J Immunol. 195:5732–5749. 2015. View Article : Google Scholar : PubMed/NCBI

95 

Wang X, Jiang W, Yan Y, Gong T, Han J, Tian Z and Zhou R: RNA viruses promote activation of the NLRP3 inflammasome through a RIP1-RIP3-DRP1 signaling pathway. Nat Immunol. 15:1126–1133. 2014. View Article : Google Scholar : PubMed/NCBI

96 

Komune N, Ichinohe T, Ito M and Yanagi Y: Measles virus V protein inhibits NLRP3 inflammasome-mediated interleukin-1β secretion. J Virol. 85:13019–13026. 2011. View Article : Google Scholar : PubMed/NCBI

97 

Komatsu T, Tanaka Y, Kitagawa Y, Koide N, Naiki Y, Morita N, Gotoh B and Yokochi T: Sendai virus V protein inhibits the secretion of interleukin-1β by preventing NLRP3 inflammasome assembly. J Virol. 92:e00842–18. 2018. View Article : Google Scholar : PubMed/NCBI

98 

Pothlichet J, Meunier I, Davis BK, Ting JP, Skamene E, von Messling V and Vidal SM: Type I IFN triggers RIG-I/TLR3/NLRP3-dependent inflammasome activation in influenza A virus infected cells. PLoS Pathog. 9:e10032562013. View Article : Google Scholar : PubMed/NCBI

99 

Park HS, Liu G, Thulasi Raman SN, Landreth SL, Liu Q and Zhou Y: NS1 protein of 2009 pandemic influenza A virus inhibits porcine NLRP3 inflammasome-mediated interleukin-1 beta production by suppressing ASC ubiquitination. J Virol. 92:e00022–18. 2018. View Article : Google Scholar : PubMed/NCBI

100 

Cheung PHH, Ye ZW, Lee TWT, Chen H, Chan CP and Jin DY: PB1-F2 protein of highly pathogenic influenza A (H7N9) virus selectively suppresses RNA-induced NLRP3 inflammasome activation through inhibition of MAVS-NLRP3 interaction. J Leukoc Biol. 108:1655–1663. 2020. View Article : Google Scholar : PubMed/NCBI

101 

Darweesh M, Kamel W, Gavrilin MA, Akusjärvi G and Svensson C: Adenovirus VA RNAI blocks ASC oligomerization and inhibits NLRP3 inflammasome activation. Front Immunol. 10:27912019. View Article : Google Scholar : PubMed/NCBI

102 

Gim E, Shim DW, Hwang I, Shin OS and Yu JW: Zika virus impairs host NLRP3-mediated inflammasome activation in an NS3-dependent manner. Immune Netw. 19:e402019. View Article : Google Scholar : PubMed/NCBI

103 

Haneklaus M, Gerlic M, Kurowska-Stolarska M, Rainey AA, Pich D, McInnes IB, Hammerschmidt W, O'Neill LA and Masters SL: Cutting edge: miR-223 and EBV miR-BART15 regulate the NLRP3 inflammasome and IL-1β production. J Immunol. 189:3795–3799. 2012. View Article : Google Scholar : PubMed/NCBI

104 

Wang H, Lei X, Xiao X, Yang C, Lu W, Huang Z, Leng Q, Jin Q, He B, Meng G and Wang J: Reciprocal regulation between enterovirus 71 and the NLRP3 inflammasome. Cell Rep. 12:42–48. 2015. View Article : Google Scholar : PubMed/NCBI

105 

Yu X, Lan P, Hou X, Han Q, Lu N, Li T, Jiao C, Zhang J, Zhang C and Tian Z: HBV inhibits LPS-induced NLRP3 inflammasome activation and IL-1β production via suppressing the NF-κB pathway and ROS production. J Hepatol. 66:693–702. 2017. View Article : Google Scholar : PubMed/NCBI

106 

Johnson KE, Chikoti L and Chandran B: Herpes simplex virus 1 infection induces activation and subsequent inhibition of the IFI16 and NLRP3 inflammasomes. J Virol. 87:5005–5018. 2013. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Zheng Q, Hua C, Liang Q and Cheng H: The NLRP3 inflammasome in viral infection (Review). Mol Med Rep 28: 160, 2023.
APA
Zheng, Q., Hua, C., Liang, Q., & Cheng, H. (2023). The NLRP3 inflammasome in viral infection (Review). Molecular Medicine Reports, 28, 160. https://doi.org/10.3892/mmr.2023.13047
MLA
Zheng, Q., Hua, C., Liang, Q., Cheng, H."The NLRP3 inflammasome in viral infection (Review)". Molecular Medicine Reports 28.3 (2023): 160.
Chicago
Zheng, Q., Hua, C., Liang, Q., Cheng, H."The NLRP3 inflammasome in viral infection (Review)". Molecular Medicine Reports 28, no. 3 (2023): 160. https://doi.org/10.3892/mmr.2023.13047
Copy and paste a formatted citation
x
Spandidos Publications style
Zheng Q, Hua C, Liang Q and Cheng H: The NLRP3 inflammasome in viral infection (Review). Mol Med Rep 28: 160, 2023.
APA
Zheng, Q., Hua, C., Liang, Q., & Cheng, H. (2023). The NLRP3 inflammasome in viral infection (Review). Molecular Medicine Reports, 28, 160. https://doi.org/10.3892/mmr.2023.13047
MLA
Zheng, Q., Hua, C., Liang, Q., Cheng, H."The NLRP3 inflammasome in viral infection (Review)". Molecular Medicine Reports 28.3 (2023): 160.
Chicago
Zheng, Q., Hua, C., Liang, Q., Cheng, H."The NLRP3 inflammasome in viral infection (Review)". Molecular Medicine Reports 28, no. 3 (2023): 160. https://doi.org/10.3892/mmr.2023.13047
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team